Full Text View
Tabular View
No Study Results Posted
Related Studies
UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling
This study is currently recruiting participants.
Study NCT00639197   Information provided by McMaster University
First Received: March 11, 2008   Last Updated: April 10, 2008   History of Changes

March 11, 2008
April 10, 2008
March 2008
June 2008   (final data collection date for primary outcome measure)
Reduction in Technical difficulty [ Time Frame: 6-8 weeks for the whole 20 pts. ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00639197 on ClinicalTrials.gov Archive Site
Signs of line related blood stream infection/bacteremia. [ Time Frame: 6-8 weeks for all 20 pts. ] [ Designated as safety issue: No ]
Same as current
 
UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling
UGIST Pilot Trial: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling. Does it Reduce the Technical Difficulty and Mechanical Complications?

The purpose of the study is to determine if tunneling standard short-term central lines for a short distance under the skin, with the assistance of ultrasound imaging, reduces the risk of central line infections for catheters placed in the neck vein.

Previous work has shown that these lines can be tunneled without ultrasound guidance. We wish to determine if the use of ultrasound makes the tunneling procedure safer and easier.

More than 250,000 vascular catheter-related bloodstream infections occur annually in the USA with a mortality ranging from 12% to 25% in critically ill patients.

It is also widely accepted that the internal jugular site is associated with a higher risk of catheter related infection if compared with the subclavian site.

Therefore, the benefit of catheter tunneling was best seen at the internal jugular site as described by J F Timsit in 1996 in his prospective randomized multicentre study where it significantly decreased the rate of catheter related sepsis from 11.4% to 3.4%.

At the same time, tunneling catheters did not increase the rate of mechanical complications such as pneumothorax, hematoma, or arterial puncture, but it almost doubled the rate of technical difficulties, such as problems with advancing the catheter or multiple puncture sites, at that time it was a blind technique.

Now, and with the introduction of the ultrasound guidance in our routine central line insertions, we would like to evaluate its benefit in reducing the technical difficulty and mechanical complications that used to be encountered while tunneling the short term central venous catheters at the internal jugular site.

 
Interventional
Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
  • Infection
  • Bacteremia
  • Procedure: To tunnel
  • Procedure: Standard (not to tunnel)
  • Active Comparator: To Tunnel
  • Active Comparator: Not to tunnel
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
20
 
June 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult ICU patients.
  • Likely to need the line for 48 hours.
  • Standard central venous catheter.

Exclusion Criteria:

  • Mechanical impedance (e.g C-spine protection).
  • Absent Internal jugular vessel on U/S.
  • Previous line still in place.
  • Presence of overlying skin or tissue infection or mass.
  • Tricuspid valve vegetation.
  • Tumor extending to the right atrium.
  • Persistent coagulopathy.
  • Newly inserted Pacemaker leads.
  • Recent carotid endarterectomy on same side.
  • No ultrasound facility available.
  • Patients requiring special lines (e.g. Dialysis).
Both
18 Years and older
No
Contact: Salah A Taqi, MBChB 905-521-2100 ext 75170 sataqi@hotmail.com
Contact: Corey Sawchuk, MD 905-527-4322 ext 46698 ctw_sawchuk@yahoo.com
Canada
 
NCT00639197
SALAH ALI TAQI, McMaster University
08-007
Hamilton Health Sciences
 
Principal Investigator: Salah A Taqi, MBChB McMaster Health Sciences
McMaster University
March 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP